UCB SA (OTCMKTS:UCBJY) Raises Dividend to $0.48 Per Share

UCB SA (OTCMKTS:UCBJY) announced a dividend on Monday, April 21st, investing.com reports. Investors of record on Tuesday, April 29th will be paid a dividend of 0.4838 per share on Wednesday, May 14th. This represents a yield of 0.62%. The ex-dividend date is Monday, April 28th. This is a 5.8% increase from UCB’s previous dividend of $0.46.

UCB Trading Up 0.4 %

Shares of UCBJY stock opened at $78.19 on Tuesday. UCB has a 12 month low of $63.58 and a 12 month high of $106.60. The company has a current ratio of 1.19, a quick ratio of 0.78 and a debt-to-equity ratio of 0.33. The firm has a fifty day moving average price of $90.94 and a 200 day moving average price of $94.45.

About UCB

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies.